Browsing by Author Cheng, Wendy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2014A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisonersHaber, Paul; Butler, Tony; Carruthers, Susan; Cheng, Wendy; Jones, Jocelyn; Lloyd, Andrew R.; Richards, Alun; Simpson, Paul; Thein, Hla-Hla; Thompson, Sandra C.; Yap, Lorraine; Central Clinical School: Addiction MedicineA descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners, PloS One, vol.9, 2, 2014,pp 1-11
2014Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studiesBooth, David; George, Jacob; McCaughan, Geoffrey William; Bollipo, Steven; Cheng, Wendy; Crawford, Darrell; Dore, Gregory; Leung, Reynold; Mitchell, Joanne; Ostapowicz, George; Roberts, Stuart; Sievert, William; Sloss, Andrew; Thompson, Alexander; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteDistribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies, Journal of Gastroenterology and Hepatology, vol.29, 1, 2014,pp 179-184
2011Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patientsWeltman, Martin; Baleriola, Cristina; Chaverot, S; Cheng, Wendy; Crawford, Darrell; Dore, Greg; Dubois, Dwight; McCaughan, Geoffrey W.; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Stelzer-Braid, Sacha; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineEffect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients, Antiviral Therapy, vol.16, 2, 2011,pp 173-180
2014IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionAhlenstiel, Golo; Booth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Leung, Reynold; Attino, Vito; Bugianesi, Elisabetta; Cheng, Wendy; Goeltz, Diane; Irving, William; Mangia, Alessandra; McLeod, Duncan; Mollison, Lindsay; Nattermann, J; Romero-Gomez, Manuel; Sheridan, David; Spengler, Ulrich; Zaitoun, Abed; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection, Journal of Hepatology, vol.61, 2, 2014,pp 235-241
2009Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.McCaughan, Geoffrey; Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Desmond, Paul V; Dore, Gregory J.; Marks, Phillipa; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Central Clinical School: Centenary Institute; Nepean Clinical School: MedicineImpact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial., Hepatology, vol.50, 4,pp 1045-1055
2014Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infectionGeorge, Jacob; Leung, Reynold; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory J.; Kitson, Matthew; McCaughan, Geoffrey W.; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, vol.29, N/A, 2014,pp 1458-1462
2010Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWeltman, Martin; Cheng, Wendy; Crawford, Darrell; Dore, Gregory J.; Marks, Phillipa; McCaughan, Geoffrey W.; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineLow virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing, Journal of Hepatology, vol.53, 4,pp 616-623
2011Virological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Dore, Gregory J.; McCaughan, Geoffrey; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Nepean Clinical School: MedicineVirological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1, Hepatology, vol.53, 4, 2011,pp 1109-1117
2013Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infectionGeorge, Jacob; McCaughan, Geoffrey; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory; Kitson, Matthew; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteVitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection, Journal of Hepatology, vol.58, 3, 2013,pp 467-472